Canada
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
47.41%
|
Dec. 31, 2023 | USD 9.31 | -2.03% |
|
Canada |
|
2 |
22.95%
|
Jan. 28, 2024 | USD 414.20 | -1.65% |
|
Canada |
|
3 |
19.44%
|
Dec. 31, 2023 | USD 51.89 | -1.06% |
|
Canada |
|
4 |
13.08%
|
Dec. 31, 2023 | USD 22.44 | -2.83% |
|
Canada |
|
5 |
12.70%
|
Dec. 31, 2023 | USD 48.67 | -2.23% |
|
Canada |
|
6 |
11.91%
|
March 31, 2024 | USD 2.13 | -19.44% |
|
Canada |
|
7 |
10.71%
|
Dec. 31, 2023 | USD 6.55 | -11.01% |
|
Canada |
|
8 |
8.87%
|
March 31, 2024 | USD 9.77 | -8.29% |
|
Canada |
|
9 |
7.02%
|
Feb. 29, 2024 | USD 48.94 | 2.70% |
|
Canada |
|
10 |
6.28%
|
Dec. 31, 2023 | USD 125.35 | -0.20% |
|
Canada |
|
11 |
5.81%
|
Dec. 31, 2023 | USD 168.34 | 0.90% |
|
Canada |
|
12 |
3.49%
|
Jan. 31, 2024 | USD 1.82 | 0.49% |
|
Canada |
|
13 |
2.82%
|
Dec. 31, 2023 | USD 16.07 | -8.97% |
|
Canada |
|
14 |
0.65%
|
March 30, 2024 | USD 1.77 | 4.73% |
|
Canada |
|
15 |
-1.10%
|
Dec. 31, 2023 | USD 6.04 | -0.70% |
|
Canada |
|
16 |
-2.89%
|
Dec. 31, 2023 | USD 4.02 | 0.45% |
|
Canada |
|
17 |
-3.15%
|
Sept. 30, 2024 | USD 1.06 | 0.04% |
|
Canada |
|
18 |
-30.21%
|
Dec. 31, 2023 | USD 2.91 | -1.79% |
|
Canada |
|
19 |
-123.17%
|
March 31, 2024 | USD 2.79 | 9.43% |
|
Canada |
|
20 |
-1,194.85%
|
Dec. 31, 2023 | USD 0.16 | 1.49% |
|
Canada |
|
21 |
-4,336.23%
|
Dec. 31, 2023 | USD 4.88 | -2.82% |
|
Canada |
The Eyewear company in Canada with the highest EBIT Margin is Cipher Pharmaceuticals Inc. (Toronto Stock Exchange: CPH.TO) at 47.41%.
The Eyewear company in Canada with the lowest EBIT Margin is POET Technologies Inc. (TSXV: PTK.V) at -4,336.23%.
The top 10 Eyewear companies in Canada by EBIT Margin are Cipher Pharmaceuticals Inc., Lululemon Athletica Inc., Gildan Activewear Inc., Jamieson Wellness Inc., CCL Industries Inc., Medexus Pharmaceuticals Inc., Bausch Health Companies Inc., Canada Goose Holdings Inc., Aritzia Inc. and Loblaw Companies Limited.
The bottom 10 Eyewear companies in Canada by EBIT Margin are POET Technologies Inc., Ondine Biomedical Inc., Canopy Growth Corporation, HLS Therapeutics Inc., Unisync Corp., Knight Therapeutics Inc., Kits Eyecare Ltd., Birks Group Inc., Bausch + Lomb Corporation and Reitmans (Canada) Limited.